Co-Diagnostics Inc. Revenue 2017–2025
Co-Diagnostics Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Co-Diagnostics Inc. revenue for the quarter ending March 31, 2026 was 145954, a 190.30% increase year-over-year.
- Co-Diagnostics Inc. revenue for the twelve months ending March 31, 2026 was 504521, a 91.89% decrease year-over-year.
- Co-Diagnostics Inc. annual revenue for 2025 was 622489, a 84.10% decrease from 2024.
- Co-Diagnostics Inc. annual revenue for 2024 was 3.9 M, a 42.53% decrease from 2023.
- Co-Diagnostics Inc. annual revenue for 2023 was 6.8 M, a 80.09% decrease from 2022.
- Co-Diagnostics Inc. annual revenue for 2022 was 34.2 M.
Co-Diagnostics Inc. (CODX) — Frequently Asked Questions
Co-Diagnostics Inc. (CODX) is a publicly traded US company. It has a market capitalization of $6M. In fiscal 2025 it reported revenue of $622,489 and net income of -$47M. Explore CODX's stock price, financial statements, earnings history, margins and key ratios below.
What is Co-Diagnostics Inc.'s market cap?
Co-Diagnostics Inc. (CODX) has a market capitalization of $6M.
What is the CODX stock price?
CODX trades at $4.88 (+8.44% on the day).
How much revenue does Co-Diagnostics Inc. make?
Co-Diagnostics Inc. reported revenue of $622,489 in fiscal 2025.
Is CODX profitable?
In fiscal 2025, Co-Diagnostics Inc. reported net income of -$47M.